BioSenic SA
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BioSenic SA is a biotechnology company focused on developing innovative clinical-stage therapies for autoimmune diseases and regenerative medicine. The company's pipeline is centered on two main platforms: a novel treatment using arsenic trioxide (ATO) to target the underlying causes of autoimmune and inflammatory conditions, and an allogeneic cell therapy platform aimed at tissue repair and organ regeneration. Formerly known as Bone Therapeutics, BioSenic combines its expertise in immunomodulation and cell therapy to address significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-29 22:00 |
Pre-Annual General Meeting Information
BioSenic SA_ Information on shareholders' rights GMs_FR_2025 09 29.pdf
|
French | 160.6 KB | ||
| 2025-09-29 22:00 |
Share Issue/Capital Change
BioSenic - (FR) Warrant_Plan - 2025 09 29.pdf
|
French | 316.3 KB | ||
| 2025-09-29 22:00 |
Management Discussion and Analysis
BioSenic - Rapport de gestion - 20250929-final.pdf
|
French | 616.8 KB | ||
| 2025-09-29 22:00 |
Audit Report / Information
BioSenic SA-rapport du commissaire-31 12 2024_signed.pdf
|
French | 1.6 MB | ||
| 2025-09-29 22:00 |
Management Discussion and Analysis
BioSenic___Rapport_spécial_CA_(Art_7_228_CSA)_2025_09_29.docx.pdf
|
French | 348.2 KB | ||
| 2025-09-29 22:00 |
Annual Report
20250817_Rapport annuel 2024_FR_Final.pdf
|
French | 2.0 MB | ||
| 2025-09-29 22:00 |
Proxy Solicitation & Information Statement
BioSenic SA_Proxy AGM_FR_2025 09 29.pdf
|
French | 422.0 KB | ||
| 2025-09-29 22:00 |
Registration Form
Comptes statutaire BNB.pdf
|
French | 352.6 KB | ||
| 2025-09-29 22:00 |
Remuneration Information
BioSenic_Remuneration Policy_2025 09 29.pdf
|
French | 248.0 KB | ||
| 2025-09-29 22:00 |
Audit Report / Information
Biosenic_Audit Opinion Conso 31 12 2024_signed.pdf
|
French | 1.6 MB | ||
| 2025-09-29 22:00 |
Pre-Annual General Meeting Information
BioSenic SA_Convening notice_2025_FR_Final.pdf
|
French | 420.5 KB | ||
| 2025-08-29 18:00 |
Report Publication Announcement
BIOS_PR_EN_2025 08_29.pdf
|
English | 213.4 KB | ||
| 2025-07-01 19:30 |
Capital/Financing Update
BIOS_PR_20250701_EN_final.pdf
|
English | 346.5 KB | ||
| 2025-07-01 19:30 |
M&A Activity
BIOS_PR_20250701_FR_final.pdf
|
French | 342.1 KB | ||
| 2025-06-10 07:30 |
Legal Proceedings Report
BIOS_PR_20250610_EN.pdf
|
English | 329.1 KB |
Automate Your Workflow. Get a real-time feed of all BioSenic SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioSenic SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
